Related Experiment Videos
[Antibacterial therapy of peritonitis]
Antibiotiki
|April 1, 1984
Abstract:
The microbiological assay of the exudate provided isolation of anaerobic pathogens in 48 (64 per cent) out of 75 patients with peritonitis. All the patients were subjected to antibacterial therapy with antibiotics and chemotherapeutic drugs active against aerobic and anaerobic pathogens.
Insights
Anaerobic pathogens were identified in 64% of peritonitis patients. All patients received broad-spectrum antibacterial therapy targeting both aerobic and anaerobic bacteria.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Medicine
Background:
- Peritonitis is a serious abdominal infection often involving polymicrobial flora.
- Identifying causative pathogens is crucial for effective treatment.
Purpose of the Study:
- To determine the prevalence of anaerobic pathogens in peritonitis exudate.
- To assess the microbiological profile of patients undergoing antibacterial therapy.
Main Methods:
- Microbiological assay of peritoneal fluid (exudate) from 75 peritonitis patients.
- Isolation and identification of anaerobic microorganisms.
- Patients received antibacterial therapy with antibiotics and chemotherapeutic drugs.
Main Results:
- Anaerobic pathogens were isolated in 48 (64%) of the 75 patients.
- The study highlights the significant role of anaerobic bacteria in peritonitis.
Conclusions:
- Anaerobic pathogens are frequently involved in peritonitis.
- Empirical antibacterial therapy should cover both aerobic and anaerobic organisms in peritonitis management.